Dongwha Pharm.Co.,Ltd (KRX: 000020)

Dongwha Pharm.Co.,Ltd Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	405,746	361,109	340,426	293,018	272,075	307,150
Other Revenue	-	-	-0	-	-	-
Revenue	405,746	361,109	340,426	293,018	272,075	307,150
Revenue Growth (YoY)	13.55%	6.08%	16.18%	7.70%	-11.42%	0.18%
Cost of Revenue	205,239	170,693	159,436	143,671	133,409	185,554
Gross Profit	200,507	190,416	180,990	149,347	138,666	121,596
Selling, General & Admin	158,554	142,338	125,515	103,217	92,288	89,486
Research & Development	21,555	21,548	19,285	17,338	16,912	16,332
Other Operating Expenses	2,399	2,291	1,993	1,808	1,930	1,713
Operating Expenses	188,337	171,750	151,075	126,848	115,588	112,081
Operating Income	12,170	18,666	29,915	22,499	23,078	9,516
Interest Expense	-1,040	-308.01	-370	-383.11	-292.15	-206.96
Interest & Investment Income	4,833	6,683	2,493	1,744	1,840	1,943
Earnings From Equity Investments	131.17	2,420	-2,269	-410.4	-114.11	6,085
Currency Exchange Gain (Loss)	298.55	377.78	31.87	687.36	-499.17	-6.93
Other Non Operating Income (Expenses)	510.63	145.65	527.55	630.9	-357.6	-980.12
EBT Excluding Unusual Items	16,904	27,985	30,328	24,768	23,655	16,349
Gain (Loss) on Sale of Investments	2,964	9,434	-4,506	1,801	2,561	-175.67
Gain (Loss) on Sale of Assets	27.84	28.76	741.89	169.46	7,462	-2.89
Asset Writedown	-376.7	-491.98	-3,478	-316.08	-39.91	70
Other Unusual Items	-	-	-	105.41	-	-
Pretax Income	19,519	36,956	23,086	26,527	33,638	16,241
Income Tax Expense	5,749	8,719	1,494	6,944	4,923	7,133
Earnings From Continuing Operations	13,770	28,237	21,591	19,583	28,715	9,108
Minority Interest in Earnings	132.28	-798.76	-1,208	-1,712	-207.41	8.38
Net Income	13,902	27,438	20,383	17,870	28,508	9,116
Net Income to Common	13,902	27,438	20,383	17,870	28,508	9,116
Net Income Growth	-52.35%	34.61%	14.06%	-37.31%	212.72%	-9.46%
Shares Outstanding (Basic)	28	28	28	28	28	28
Shares Outstanding (Diluted)	28	28	28	28	28	28
Shares Change (YoY)	0.09%	0.02%	0.16%	0.05%	0.05%	-
EPS (Basic)	501.80	991.07	736.42	646.68	1032.60	330.20
EPS (Diluted)	501.80	991.07	736.42	646.68	1032.51	330.00
EPS Growth	-52.40%	34.58%	13.88%	-37.37%	212.88%	-9.51%
Free Cash Flow	-14,338	4,626	10,792	14,087	17,982	8,488
Free Cash Flow Per Share	-517.51	167.09	389.91	509.78	651.02	307.44
Dividend Per Share	180.000	180.000	180.000	180.000	180.000	-
Gross Margin	49.42%	52.73%	53.17%	50.97%	50.97%	39.59%
Operating Margin	3.00%	5.17%	8.79%	7.68%	8.48%	3.10%
Profit Margin	3.43%	7.60%	5.99%	6.10%	10.48%	2.97%
Free Cash Flow Margin	-3.53%	1.28%	3.17%	4.81%	6.61%	2.76%
EBITDA	28,119	32,562	42,424	34,591	33,785	21,000
EBITDA Margin	6.93%	9.02%	12.46%	11.81%	12.42%	6.84%
D&A For EBITDA	15,949	13,896	12,509	12,093	10,707	11,485
EBIT	12,170	18,666	29,915	22,499	23,078	9,516
EBIT Margin	3.00%	5.17%	8.79%	7.68%	8.48%	3.10%
Effective Tax Rate	29.45%	23.59%	6.47%	26.18%	14.64%	43.92%
Advertising Expenses	-	41,140	34,455	29,889	27,532	29,163

Source: S&P Capital IQ. Standard template. Financial Sources.